IQVIQVIA HOLDINGS INC.

NYSE iqvia.com


$ 237.52 $ 1.40 (0.59 %)    

Friday, 09-Aug-2024 15:59:59 EDT
QQQ $ 450.22 $ 2.34 (0.52 %)
DIA $ 395.16 $ 0.63 (0.16 %)
SPY $ 532.81 $ 2.34 (0.44 %)
TLT $ 96.28 $ 0.94 (0.99 %)
GLD $ 224.54 $ 0.55 (0.25 %)
$ 237.47
$ 237.60 x 100
-- x --
-- - --
$ 167.42 - $ 261.73
552,564
na
43.77B
$ 1.38
$ 30.76
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-22-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-15-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-15-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-22-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-16-2022 12-31-2021 10-K
12 10-22-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-23-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 10-22-2020 09-30-2020 10-Q
17 07-23-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 11-01-2019 09-30-2019 10-Q
21 07-24-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 10-25-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 05-04-2018 03-31-2018 10-Q
27 02-16-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-08-2017 03-31-2017 10-Q
31 02-16-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 07-27-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-11-2016 12-31-2015 10-K
36 10-28-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-29-2015 03-31-2015 10-Q
39 02-12-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-iqvia-hldgs-raises-price-target-to-288

JP Morgan analyst Anne Samuel maintains IQVIA Hldgs (NYSE:IQV) with a Overweight and raises the price target from $260 to $288.

 jefferies-downgrades-iqvia-hldgs-to-hold-lowers-price-target-to-242

Jefferies analyst David Windley downgrades IQVIA Hldgs (NYSE:IQV) from Buy to Hold and lowers the price target from $266 to ...

 morgan-stanley-maintains-overweight-on-iqvia-hldgs-raises-price-target-to-280

Morgan Stanley analyst Tejas Savant maintains IQVIA Hldgs (NYSE:IQV) with a Overweight and raises the price target from $270...

 ubs-maintains-buy-on-iqvia-hldgs-raises-price-target-to-300

UBS analyst Dan Brennan maintains IQVIA Hldgs (NYSE:IQV) with a Buy and raises the price target from $295 to $300.

 truist-securities-maintains-buy-on-iqvia-hldgs-raises-price-target-to-300

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:IQV) with a Buy and raises the price target from $292 ...

 evercore-isi-group-maintains-outperform-on-iqvia-hldgs-raises-price-target-to-270

Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Hldgs (NYSE:IQV) with a Outperform and raises the price target...

 barclays-maintains-overweight-on-iqvia-hldgs-raises-price-target-to-275

Barclays analyst Luke Sergott maintains IQVIA Hldgs (NYSE:IQV) with a Overweight and raises the price target from $255 to $275.

 baird-maintains-neutral-on-iqvia-hldgs-raises-price-target-to-251

Baird analyst Eric Coldwell maintains IQVIA Hldgs (NYSE:IQV) with a Neutral and raises the price target from $235 to $251.

 us-stocks-rebound-as-tech-surges-crowdstrike-continues-selloff-oil-hits-1-month-lows-whats-driving-markets-monday

Wall Street started the new week on a positive note, with all major indices in the green. A rebound in tech stocks following la...

 iqvia-is-a-solid-investment-with-strong-competitive-positioning-analyst-says-after-better-than-expected-q2-earnings

IQVIA Holdings Inc (NASDAQ:IQV) reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.

 baird-maintains-neutral-on-iqvia-hldgs-lowers-price-target-to-235

Baird analyst Eric Coldwell maintains IQVIA Hldgs (NYSE:IQV) with a Neutral and lowers the price target from $241 to $235.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION